Gene Therapy Solution protects employee health and ASO employer costs

Emerging gene therapies show great promise for treatment of difficult rare conditions, but carry significant risk in terms of cost. Our Gene Therapy Solution works as a provision of our stop loss-policy to protect your administrative services only (ASO) National and Large Group clients from unknown financial risk while providing access to robust care management for individuals with rare and complex conditions. We continually update the Gene Therapy Solution web resource when new treatments are added.

You can also view a recording of our recent Gene Therapy webinar.